Opportunity Information: Apply for PAR 25 347
The Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed), funding opportunity number PAR-25-347, is a National Institutes of Health grant mechanism designed to help doctoral candidates finish their dissertation research in the area of substance use and substance use disorder (SU(D)). The program is run through NIH with a focus aligned to the National Institute on Drug Abuse (NIDA) mission, and it supports students from a wide range of academic disciplines who are conducting research that fits NIDA priorities. The central idea is to provide time-limited, dissertation-stage support so promising researchers can complete rigorous projects and transition into the SU(D) research workforce.
This opportunity funds up to two years of dissertation research support. Proposed projects are expected to align with NIDA funding priorities (as outlined on NIDA's funding priorities page) or with the goals laid out in the NIDA Strategic Plan. In practical terms, that means applicants should clearly connect their dissertation aims to the kinds of scientific and public health questions NIDA emphasizes, such as understanding the causes and consequences of substance use, improving prevention and treatment approaches, addressing overdose and related harms, studying comorbid conditions, and improving the translation of evidence into real-world settings, among other areas reflected in NIDA's priority framework.
A major stated purpose of the award is workforce development: it is meant to speed the entry of new investigators into SU(D) research and strengthen the overall pipeline of highly trained researchers in this field. The NOFO also explicitly encourages applications from candidates who can help diversify the biomedical, behavioral, clinical, and social science research workforce, consistent with NIH's broader Notice of Interest in Diversity (NOT-OD-20-031). In other words, beyond the scientific value of the dissertation itself, NIDA is signaling that it values applicants and training environments that broaden participation and perspectives within SU(D) research.
The NOFO is labeled "Clinical Trials Not Allowed," which is an important boundary on what can be proposed. Applicants need to ensure the dissertation work does not meet NIH's definition of a clinical trial, meaning the project should not involve prospectively assigning human participants to an intervention to evaluate effects on health-related outcomes. Observational human subjects research, secondary data analyses, and other non-trial designs may still be possible, but the application must be structured so it remains outside clinical trial territory under NIH policy.
Eligibility spans a broad range of applicant organizations, reflecting NIH's general institutional eligibility rules for grants in this category. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments and certain tribal organizations; public housing authorities/Indian housing authorities; nonprofits (both 501(c)(3) and non-501(c)(3), excluding institutions of higher education where applicable); for-profit organizations other than small businesses; and small businesses, among others. The NOFO additionally highlights institutions and organizations that NIH often seeks to ensure are fully aware of eligibility and encouraged to participate, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations and eligible federal agencies.
There are also clear restrictions related to foreign involvement. Non-domestic (non-U.S.) entities (foreign organizations) are not eligible to apply directly, and non-domestic components of U.S. organizations are not eligible to apply. However, "foreign components" (as NIH defines them in the NIH Grants Policy Statement) are allowed, which typically means a U.S. applicant institution may, under NIH rules and with appropriate justification and oversight, include certain foreign activities or collaborations as part of the project when they are necessary for the science.
Administratively, the opportunity is categorized as a discretionary grant within the Education and Health activity area and is associated with CFDA number 93.279. The agency is the National Institutes of Health, the opportunity record shows a creation date of January 2, 2025, and the listed closing date is September 7, 2026. The award ceiling and expected number of awards are not specified in the provided source text, so applicants would need to consult the full NOFO and NIH budget guidance for allowable costs, caps, and other budget parameters.Apply for PAR 25 347
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2025-01-02.
- Applicants must submit their applications by 2026-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Cooperative Agreement for affiliated Partner with Great Lakes – Northern Forest Cooperative Ecosystem Studies Unit (CESU)
Previous opportunity: Native Hawaiian Library Services Grants (2025)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 25 347
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 25 347) also looked into and applied for these:
| Funding Opportunity |
|---|
| Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) Apply for PAR 25 329 Funding Number: PAR 25 329 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) Apply for PAR 25 328 Funding Number: PAR 25 328 Agency: National Institutes of Health Category: Education, Health Funding Amount: $5,000,000 |
| Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional) Apply for PAR 25 324 Funding Number: PAR 25 324 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed) Apply for PAR 25 377 Funding Number: PAR 25 377 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional) Apply for RFA NR 25 004 Funding Number: RFA NR 25 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Multimodal Artificial Intelligence to Accelerate HIV Clinical Care (R01 Clinical Trial Optional) Apply for RFA MH 26 105 Funding Number: RFA MH 26 105 Agency: National Institutes of Health Category: Education, Health Funding Amount: $750,000 |
| Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) Apply for PAR 25 342 Funding Number: PAR 25 342 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Pathway to Independence Award (K99/R00 Clinical Trial Required) Apply for PAR 25 313 Funding Number: PAR 25 313 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) Apply for PAR 24 300 Funding Number: PAR 24 300 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) Apply for PAR 25 446 Funding Number: PAR 25 446 Agency: National Institutes of Health Category: Education, Health Funding Amount: $3,000,000 |
| Community-Partnered Nursing Research Centers (P20 Clinical Trial Optional) Apply for PAR 25 439 Funding Number: PAR 25 439 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed) Apply for RFA DA 26 020 Funding Number: RFA DA 26 020 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 25 347", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
